EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Partnerships in Cell and Gene Therapies Press Releases

partnering360:Insight Latest headlines from partnering360:Insight

May 25, 2017 Where are they now? Cocoon Biotech planning tox studies Recognition from a high profile organization like the BioPharm America™ conference has been tremendous for Cocoon,” Ailis Tweed-Kent, MD, founder and CEO of Cocoon Biotech says. Winning the overall competition for pitches and most investible company during the Startup Day event at the 2016 conference “validates the company and our vision. As a result, we’ve received additional interest from investors and collaborators." more ►

May 25, 2017 Where are they now? For Virvio, it’s all about visibility When Virvio participated in BioPharm America™’s Startup Day pitch contest in 2016, the company had been operational less than one year. It had three employees and was operating under grants from the National Institutes of Health (NIH) and other government funding mechanisms to advance its preclinical influenza assets from its offices in the University of Washington incubator. It was the second runner up. more ►

May 18, 2017 TxCell plans first-in-man trial of regulatory T cells Having completed a Phase I/IIa study of Ovasave, a drug candidate from its first generation non-modified antigen-specific regulatory T cells (Tregs), TxCell expects to start a first-in-man study of another candidate. more ►

May 18, 2017 Mitochondrial medicine focus drives NeuroVive orphan ambitions Underpinned by a profound understanding of genetic mitochondrial disorders, Swedish biotech NeuroVive Pharmaceutical AB is pursuing a two-pronged orphan and speciality pharma approach. more ►

May 18, 2017 vitalityDNA plans to keep healthy indviduals healthy Precision medicines, the microbiome and a growing focus on wellness are some of the latest tools used by London-based startup vitalityDNA to provide customers with personalized health and lifestyle plans. more ►

Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use